A case of herpetiform pemphigus mimicking bullous pemphigoid after using secukinumab and successfully treated with sulfasalazine
The Journal of Dermatology · 2023
DOI: 10.1111/1346-8138.16936 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Dermatology, 2023. Verfasst von Rui Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Pemphigus, Psoriasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Interleukin 17A (IL‐17A) inhibitors, such as secukinumab, have been widely used as the mainstream treatment for chronic plaque psoriasis; however, cutaneous adverse events have been reported. Here, we report a 43‐year‐old Chinese man who developed herpetiform pemphigus (HP) during secukinumab treatment for his psoriasis. He presented with (1) clinical features of HP, which resembled bullous pemphigoid; histopathological features of intraepidermal blisters, eosinophilic/neutrophilic spongiosis, and liquefactive degeneration of the basal cell layer; (3) positive anti‐desmoglein 1 antibody by enzyme‐linked immunosorbent assay and cell surface IgG reactivity within the epidermis by indirect immunofluorescence assay; and (4) a satisfactory response to salicylazosulfapyridine (sulfasalazine). To the best of our knowledge, this is the first report of the development of HP after the use of secukinumab for psoriasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Peking University First Hospital, Beijing, China.
- National Clinical Research Center for Skin and Immune Diseases, Beijing, China.
- Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
- NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China.
ORCID-Profile: Mingyue Wang
Zitieren
APA
Wang, R., & Wang, M. (2023). A case of herpetiform pemphigus mimicking bullous pemphigoid after using secukinumab and successfully treated with sulfasalazine. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.16936
Vancouver
Wang R, Wang M. A case of herpetiform pemphigus mimicking bullous pemphigoid after using secukinumab and successfully treated with sulfasalazine. The Journal of Dermatology. 2023. doi:10.1111/1346-8138.16936
BibTeX
@article{Wang2023,
author = {Wang, Rui and Wang, Mingyue},
title = {A case of herpetiform pemphigus mimicking bullous pemphigoid after using secukinumab and successfully treated with sulfasalazine},
journal = {The Journal of Dermatology},
year = {2023},
doi = {10.1111/1346-8138.16936}
}
EUVIMED